About
Culture Biosciences offers an end-to-end suite of products and services purpose-built for bioprocess development in the life sciences. At its core is Console, a secure cloud-based software platform that serves as a unified hub for managing all cell culture experiments, data, and analytics. Console enables real-time monitoring, remote collaboration, and AI/ML-driven insights—giving teams the ability to run and analyze experiments as though the bioreactors were in their own lab. Stratyx is Culture's mobile laboratory bioreactor platform, offering enhanced flexibility and scalability in both 250mL bench-scale and 5L single-use bioreactor formats. Stratyx integrates directly with Console, streaming live process data to the cloud for instant access and analysis. Nexxys, Culture's CRO service offering, allows organizations to outsource entire bioprocessing workflows—from clone and strain screening to process characterization, development, and bioprocess modeling—without the capital investment of in-house infrastructure. The platform supports a wide range of applications, including synthetic biology, protein therapeutics, and viral vector development. Culture Biosciences is designed for biopharmaceutical companies, biotech startups, and research institutions looking to remove bottlenecks, improve data availability, and accelerate time to IND or commercialization. By consolidating hardware, software, and services into one seamlessly integrated ecosystem, Culture makes high-quality bioprocess development more accessible, scalable, and data-driven.
Key Features
- Console Cloud Software: A secure, cloud-native platform for managing all bioreactor experiments, real-time data monitoring, and AI/ML-powered bioprocess analytics from any device.
- Stratyx Bioreactor Hardware: Mobile, single-use laboratory bioreactors (250mL and 5L) with cloud connectivity for enhanced flexibility and scalability in bioprocess workflows.
- Nexxys Bioprocessing Services: Full-service CRO offerings covering clone/strain/construct screening, process characterization, development, and bioprocess modeling and simulation.
- Real-Time Remote Monitoring: Monitor and manage live cell culture experiments remotely in real-time, with data streaming directly to the cloud for instant access and team collaboration.
- AI/ML Bioprocess Insights: Integrated AI and machine learning tools surface actionable insights from experimental data to optimize processes and accelerate decision-making.
Use Cases
- Biopharmaceutical teams running fed-batch CHO cell culture processes who need real-time remote monitoring without on-site lab presence.
- Biotech startups screening clones, strains, and constructs early in drug development without the overhead of building in-house bioreactor infrastructure.
- Research teams conducting process characterization and development studies using Nexxys CRO services to outsource experimental runs.
- Distributed or hybrid lab teams collaborating across locations using Console's cloud-based data sharing and analytics tools.
- Organizations developing viral vectors or protein therapeutics who require scalable, single-use bioreactor platforms integrated with AI-driven process optimization.
Pros
- Fully Integrated Ecosystem: Hardware, cloud software, and CRO services are seamlessly unified, eliminating the need to stitch together disparate tools and vendors.
- Remote Experiment Management: Scientists can design, monitor, and analyze experiments from anywhere, enabling distributed teams and eliminating lab-location bottlenecks.
- Reduces Capital Infrastructure Costs: Through Nexxys services and single-use bioreactors, organizations can run sophisticated bioprocessing without heavy upfront facility investment.
- AI-Driven Optimization: Built-in AI/ML capabilities help teams extract deeper insights from bioprocess data, shortening development cycles.
Cons
- Highly Specialized Use Case: The platform is purpose-built for bioprocessing and cell culture, making it irrelevant for organizations outside the life sciences sector.
- Enterprise Pricing with No Self-Serve Tier: Access requires scheduling a demo, suggesting premium enterprise pricing with no free trial or self-serve onboarding option.
- Hardware Dependency: Full platform value requires use of Stratyx bioreactor hardware, which may limit adoption for labs already invested in other bioreactor systems.
Frequently Asked Questions
Culture Biosciences is a bioprocess development company offering cloud-connected bioreactors (Stratyx), cloud-native management software (Console), and outsourced bioprocessing services (Nexxys) to help life science organizations accelerate R&D and reduce time to market.
Console is a secure, cloud-based platform that acts as a central hub for all cell culture experiments. It provides real-time data monitoring, advanced analytics, AI/ML insights, and remote collaboration tools, accessible from any device.
Stratyx is Culture Biosciences' mobile laboratory bioreactor system, available in 250mL bench-scale and 5L single-use formats. It connects directly to Console to stream live process data to the cloud.
The platform is designed for biopharmaceutical companies, biotech startups, and research institutions working on cell culture processes such as protein therapeutics, viral vectors, and synthetic biology applications.
Culture supports a broad range of bioprocessing applications including synthetic biology, protein therapeutics, viral vector development, clone/strain screening, process characterization, and bioprocess modeling and simulation.
